Dong Quai and menopause

What 3 graded rows on dong quai agree on for menopause, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Dong Quai page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Dong Quai page, with its PubMed record.

Supplement

Dong Quai Choose another

3 rows · 231 people

Mostly no difference: 2 of 3 rows, and most of the people. 1 had mixed results.

No difference or mixed

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside. Outlined: mixed results.

From the rows

The best-graded row, grade C, is a randomized trial of 100 people (2008) and found no difference.

The rows run from 60 to 100 people, published from 1997 to 2013: 3 single studies.

2 no difference · 1 mixed

Grade CHot flushes and night sweats · No difference
RCT · n 100 · 2008 · Symptomatic menopausal women in Hong Kong
Not stated in the abstract · 6 months
No overall difference from placebo for vasomotor symptoms; only mild hot flushes fell more than with placebo, while night sweats and moderate flushes improved more with placebo. No serious adverse events.
Row on the Dong Quai page · PubMed 18568789 (opens PubMed)
Grade CHot flushes, Kupperman index and estrogen markers · No difference
RCT · n 71 · 1997 · Postmenopausal women with hot flashes (mean age 52)
Not stated in the abstract · 24 weeks
No difference from placebo in hot-flash count, Kupperman index, endometrial thickness or vaginal maturation.
Row on the Dong Quai page · PubMed 9418683 (opens PubMed)
Grade DHot flushes, night sweats and quality of life by dose · Mixed
RCT · n 60 · 2013 · Postmenopausal women with severe hot flashes and night sweats
1.5, 3.0 or 6.0 g/day · 12 weeks
Symptoms fell from baseline at 3.0 and 6.0 g/day, most at 6.0 g/day; hormones and lipids did not change. There was no placebo group.
Row on the Dong Quai page · PubMed 22990757 (opens PubMed)